SBRA

19.28

1.68% -0.33

Handel nachbörslich: 19.27 -0.01 -0.05%

Sabra Healthcare Reit Inc (SBRA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$19.61

Offen:

$19.725

24-Stunden-Volumen:

1.92M

Relative Volume:

0.66

Marktkapitalisierung:

$4.81B

Einnahmen:

$724.83M

Nettoeinkommen (Verlust:

$182.33M

KGV:

25.36

EPS:

0.7602

Netto-Cashflow:

$338.84M

1W Leistung:

+0.68%

1M Leistung:

-0.16%

6M Leistung:

+4.22%

1J Leistung:

+12.22%

1-Tages-Spanne:

$19.21

$19.82

1-Wochen-Bereich:

$18.36

$19.82

52-Wochen-Spanne:

$15.60

$19.97

Sabra Healthcare Reit Inc Stock (SBRA) Company Profile

Firmenname

Sabra Healthcare Reit Inc

Sektor

Real Estate (265)

Branche

REIT - Healthcare Facilities (17)

Telefon

888-393-8248

Adresse

1781 FLIGHT WAY, TUSTIN, CA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-10-31

Neueste SEC-Einreichungen

SBRA's Discussions on Twitter

Vergleichen Sie SBRA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SBRA Sabra Healthcare Reit Inc	19.28	4.89B	724.83M	182.33M	338.84M	0.7602
WELL Welltower Inc	186.08	127.87B	9.90B	967.82M	1.88B	1.3269
VTR Ventas Inc	74.90	35.27B	5.56B	247.25M	1.24B	0.5291
OHI Omega Healthcare Investors Inc	44.27	13.20B	1.08B	448.00M	779.91M	1.61
DOC Healthpeak Properties Inc	16.71	11.84B	2.80B	279.29M	1.20B	0.40
AHR American Healthcare Reit Inc	47.28	8.43B	2.07B	-37.81M	84.15M	-0.27

Sabra Healthcare Reit Inc Stock (SBRA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-18	Eingeleitet	UBS	Neutral
2025-10-01	Eingeleitet	Cantor Fitzgerald	Neutral
2025-01-17	Herabstufung	Truist	Buy → Hold
2025-01-07	Hochstufung	JMP Securities	Mkt Perform → Mkt Outperform
2024-12-05	Herabstufung	Mizuho	Outperform → Neutral
2024-10-01	Hochstufung	Wells Fargo	Equal Weight → Overweight
2024-09-13	Hochstufung	Citigroup	Neutral → Buy
2024-01-30	Eingeleitet	Deutsche Bank	Buy
2023-10-17	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2023-10-16	Hochstufung	Wells Fargo	Underweight → Equal Weight
2023-10-10	Hochstufung	BofA Securities	Neutral → Buy
2023-10-03	Eingeleitet	Wedbush	Outperform
2023-09-20	Hochstufung	Jefferies	Hold → Buy
2023-08-11	Hochstufung	BofA Securities	Underperform → Neutral
2023-07-27	Eingeleitet	Berenberg	Hold
2023-04-20	Eingeleitet	Wells Fargo	Underweight
2022-12-13	Herabstufung	JMP Securities	Mkt Outperform → Mkt Perform
2022-11-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-10-10	Herabstufung	Robert W. Baird	Outperform → Neutral
2022-06-30	Herabstufung	Jefferies	Buy → Hold
2022-06-03	Eingeleitet	CapitalOne	Equal Weight
2022-05-25	Hochstufung	Mizuho	Neutral → Buy
2022-04-18	Herabstufung	Barclays	Overweight → Equal Weight
2022-03-11	Hochstufung	BofA Securities	Underperform → Neutral
2022-02-18	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2022-02-01	Eingeleitet	Credit Suisse	Neutral
2021-10-08	Eingeleitet	Robert W. Baird	Outperform
2021-09-30	Hochstufung	Truist	Hold → Buy
2021-07-14	Fortgesetzt	Mizuho	Neutral
2021-05-21	Hochstufung	BMO Capital Markets	Market Perform → Outperform
2021-05-10	Hochstufung	Stifel	Hold → Buy
2021-01-13	Hochstufung	Jefferies	Hold → Buy
2021-01-13	Herabstufung	Mizuho	Buy → Neutral
2021-01-08	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2020-12-03	Hochstufung	JMP Securities	Mkt Perform → Mkt Outperform
2020-09-02	Fortgesetzt	Stifel	Hold
2020-06-23	Hochstufung	Scotiabank	Sector Underperform → Sector Perform
2020-06-08	Fortgesetzt	JMP Securities	Mkt Perform
2020-05-18	Hochstufung	Berenberg	Hold → Buy
2020-03-23	Herabstufung	BofA/Merrill	Neutral → Underperform
2020-02-26	Hochstufung	Mizuho	Neutral → Buy
2020-02-05	Eingeleitet	Berenberg	Hold
2019-12-20	Eingeleitet	Mizuho	Neutral
2019-12-18	Hochstufung	Citigroup	Sell → Neutral
2019-10-14	Fortgesetzt	BofA/Merrill	Neutral
2019-09-23	Herabstufung	Citigroup	Neutral → Sell
2019-09-03	Eingeleitet	Barclays	Overweight
2018-12-18	Herabstufung	SunTrust	Buy → Hold
2018-11-16	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-05-21	Hochstufung	Raymond James	Mkt Perform → Outperform
2018-03-26	Hochstufung	BofA/Merrill	Underperform → Neutral
2018-02-22	Bestätigt	Stifel	Hold
2017-12-21	Herabstufung	Jefferies	Buy → Hold
2017-09-25	Eingeleitet	CapitalOne	Equal Weight

Alle ansehen

Sabra Healthcare Reit Inc Aktie (SBRA) Neueste Nachrichten

Jan 09, 2026

UBS Remains a Hold on Sabra Healthcare REIT (SBRA) - The Globe and Mail

Jan 09, 2026

Jan 08, 2026

Sabra Healthcare REIT Announces Executive Leadership Transition - TipRanks

Jan 08, 2026

Does Sabra’s CIO Transition to Insider Darrin Smith Reshape the Bull Case for Sabra Health Care REIT (SBRA)? - simplywall.st

Jan 08, 2026

Jan 06, 2026

Sabra Health Care REIT (SBRA) stock slips in premarket after naming new chief investment officer - TechStock²

Jan 06, 2026

Sabra Health Care REIT names Darrin Smith as new chief investment officer By Investing.com - Investing.com Nigeria

Jan 06, 2026

Jan 05, 2026

Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement - Business Wire

Jan 05, 2026

Jan 03, 2026

Pacer Advisors Inc. Purchases 43,732 Shares of Sabra Healthcare REIT, Inc. $SBRA - Defense World

Jan 03, 2026

Sabra Healthcare REIT (NASDAQ:SBRA) Upgraded at Wall Street Zen - MarketBeat

Jan 03, 2026

Jan 01, 2026